In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Mersana Therapeutics (MRSN – Research Report). The company’s ...

Fintel reports that on February 6, 2025, William Blair initiated coverage of Mersana Therapeutics (NasdaqGS:MRSN) with a ...

William Blair initiated coverage on Mersana Therapeutics, Inc. (NASDAQ:MRSN) with an Outperform rating. The firm's analyst cited the company's potential in the antibody-drug conjugates (ADCs) market ...

Despite some market exclusivity concerns, GERN still has many years of sales ahead, unencumbered by generic competition.

Then you’ll want to hear this. On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried ...

Learn More *Stock prices used were the morning prices of Jan. 27, 2025. The video was published on Jan. 28, 2025. Matt Frankel has positions in Berkshire Hathaway, General Motors, MercadoLibre ...

Follow Yahoo Finance Canada for more weekly gas price updates. Scroll below to find your nearest city.

Netflix Inc. is raising prices again — though for some viewers, it’s actually been some time since the last hike. The company announced alongside its earnings Tuesday afternoon that it will be ...

The average 1 year target price among brokers that have covered the stock in the last year is $5.57. MRSN has been the topic of a number of recent research reports. Wedbush reaffirmed an ...